Registered entities
Rewind Therapeutics
Reg. No. 0682.626.216Belgium
Innovation
2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 97 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Investor mix
8 investors on record; lead investors include Sunstone, Boehringer Ingelheim Venture Fund, M Ventures, PMV.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 3 | 38% |